Check out the companies that are trending in pre-market trading. Novo Nordisk — Shares rose about 5%, recovering from the nearly 18% decline seen in the previous session. On Friday, the Danish pharmaceutical giant’s experimental weight loss drug Kaglisema reported disappointing late-stage trial results. Honda – The U.S.-listed stock rose 15% after Honda officially began merger talks with fellow Japanese automaker Nissan. The carmaker plans to conclude talks in June 2025. Xerox — The document services provider rose nearly 7% after announcing the acquisition of printer maker Lexmark. The deal is worth $1.5 billion. Occidental Petroleum , Sirius . Occidental and SiriusXM each rose more than 2%, while Verisign rose 1.8%. Tesla — The electric car maker rallied 3% before the bell, regaining some momentum from last week’s decline. Tesla fell 3.5% last week, its worst weekly performance since before the US presidential election. Despegar.com — Shares soared 32% after Prosus entered into a definitive agreement to acquire the Argentina-based online travel platform for $19.50 per share. Prosus will pay $1.7 billion as part of the transaction, which is expected to close in the second quarter of 2025. Traws Pharma — Shares of clinical-stage virology company Traws Pharma soared more than 76% after announcing progress in developing a treatment. H5N1 avian influenza. The company announced that tivoxavir marboxil showed safety and tolerability in Phase 1 trials and will begin Phase 2 trials early next year. The news comes amid expectations that the threat of bird flu will increase. Immunocore — The biotech stock rose more than 5% after the company said the first patient had received the company’s experimental immunotherapy treatment, IMC-0115C. — CNBC’s Sean Conlon and Christina Cheddar Burke contributed reporting
NVO, HMC, XRX, TSLA etc.
